ANVISA registration 10259610242Valid until Dec 10, 2028

LEPTOSPIRA SP

Name: LEPTOSPIRA SP — ANVISA registration 10259610242
Creator: VIRCELL MICROBIOLOGISTS
Keywords: LEPTOSPIRA SP, LEPTOSPIRA SP, Leptospira Virclia IgM Monotest, 10259610242, Risk Class III, ANVISA registration

ANVISA Registration Number: 10259610242MEDIVAX INDÚSTRIA E COMÉRCIO LTDAVIRCELL MICROBIOLOGISTSRisk Class III

Verified

Device names

Technical name: LEPTOSPIRA SP
Commercial name: Leptospira Virclia IgM Monotest
Risk class: Class III

Registration details

Registration Number: 10259610242
Process Number: 25351155493202360
CNPJ: 68814961000173

Company information

Registration Holder: MEDIVAX INDÚSTRIA E COMÉRCIO LTDA
Manufacturer: VIRCELL MICROBIOLOGISTS
Manufacturing Country: Spain

Dates and status

Publication Date: Mar 27, 2023
Validity: 10/12/2028
Last Updated: 08/18/2026 19:00:00

About this record

Access comprehensive regulatory information for LEPTOSPIRA SP in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 10259610242 and manufactured by VIRCELL MICROBIOLOGISTS. The registration is held by MEDIVAX INDÚSTRIA E COMÉRCIO LTDA with validity until Dec 10, 2028.

This page shows the facts attached to this official registry row. Exact-name links return deterministic registry matches; open-ended comparison and market analysis are handed to AI Search with this record's context, without asserting that similar names represent the same entity.